Vancomycin Dosing for Serious MRSA Infections: A Non-inferiority Randomized Trial of Trough Level Versus AUC/MIC
Vancomycin Dosing for Serious MRSA Infections: A Non-inferiority Randomized Trial of Trough Level Versus AUC/MIC
Recruiting · NCT04793152 · Registry updated 2026-01-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Vancomycin Dosing for Serious MRSA Infections: A Non-inferiority Randomized Trial of Trough Level Versus AUC/MIC | methicillin-resistant staphylococcus aureus infectious disease | Recruiting | Not applicable | 2026-01-23 | NCT04793152 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Anthony Bai | 1 |
| Canadian Institutes of Health Research (CIHR) | 339 |
| Physician Services Incorporated | 1 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hamilton Health Sciences | Hamilton | Canada | 14 |
| Kingston Health Sciences Centre | Kingston | Canada | 91 |
| McGill University Health Centre | Montreal | Canada | 4 |
| St. Joseph's Healthcare Hamilton | Hamilton | Canada | 27 |